These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G; Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262 [TBL] [Abstract][Full Text] [Related]
6. Quality of life in multiple sclerosis: effects of current treatment options. Kargiotis O; Paschali A; Messinis L; Papathanasopoulos P Int Rev Psychiatry; 2010; 22(1):67-82. PubMed ID: 20233115 [TBL] [Abstract][Full Text] [Related]
8. Are there protective treatments for cognitive decline in MS? Amato MP; Portaccio E; Zipoli V J Neurol Sci; 2006 Jun; 245(1-2):183-6. PubMed ID: 16643949 [TBL] [Abstract][Full Text] [Related]
9. The association between cognitive impairment and quality of life in patients with early multiple sclerosis. Glanz BI; Healy BC; Rintell DJ; Jaffin SK; Bakshi R; Weiner HL J Neurol Sci; 2010 Mar; 290(1-2):75-9. PubMed ID: 19944429 [TBL] [Abstract][Full Text] [Related]
10. Disease progression in pediatric multiple sclerosis: disparities between physical and neurocognitive outcomes. Yeh EA; Parrish JB; Weinstock-Guttman B Expert Rev Neurother; 2011 Mar; 11(3):433-40. PubMed ID: 21375448 [TBL] [Abstract][Full Text] [Related]
11. [The possibilities of neuropsychological rehabilitation in multiple sclerosis]. Rosti-Otajärvi E; Hämäläinen P Duodecim; 2010; 126(24):2845-52. PubMed ID: 21268907 [TBL] [Abstract][Full Text] [Related]
12. [Neuropsychological evaluation and psychopathology of multiple sclerosis]. Defer G Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1128-34. PubMed ID: 11787345 [TBL] [Abstract][Full Text] [Related]
13. [Cognitive and emotional disorders in multiple sclerosis. Can a management strategy be envisioned?]. Pelletier J; Benoit N; Montreuil M; Habib M Pathol Biol (Paris); 2000 Mar; 48(2):121-31. PubMed ID: 10815288 [TBL] [Abstract][Full Text] [Related]
14. Cognitive dysfunction evaluation in multiple sclerosis patients treated with interferon beta-1b: an open-label prospective 1 year study. Flechter S; Vardi J; Finkelstein Y; Pollak L Isr Med Assoc J; 2007 Jun; 9(6):457-9. PubMed ID: 17642394 [TBL] [Abstract][Full Text] [Related]
15. The cognitive burden of multiple sclerosis in children. Banwell BL; Anderson PE Neurology; 2005 Mar; 64(5):891-4. PubMed ID: 15753431 [TBL] [Abstract][Full Text] [Related]